Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU792
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors on December 16, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle designated SPE2DX and active through December 2026. The delivery order specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026.
SKYRIZI is a biologic medication used primarily for immunological conditions, and this delivery order demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor for military and federal healthcare systems. The award reflects the company's competitive standing within DLA's medical supply chain and its capability to fulfill specialized pharmaceutical procurement requirements on an accelerated timeline. As a major healthcare solutions provider serving the Defense Health Agency, U.S. Coast Guard, and other government medical programs, AmerisourceBergen leverages its prime vendor status to supply brand-name medications, generics, vaccines, and specialized medical devices across multiple therapeutic domains in support of military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FU792?
SPE2DR26FU792 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FU792 worth?
The government has obligated $12,467 on SPE2DR26FU792.
Is contract SPE2DR26FU792 an order under another contract?
Yes. SPE2DR26FU792 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU792 competed?
The extent of competition for SPE2DR26FU792 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award